CytoDyn to Meet with Quest Clinical Research to Finalize Phase II Strategy for Novel AIDS Drug.
Linked as:
Extract
CytoDyn to Meet with Quest Clinical Research to Finalize Phase II Strategy for Novel AIDS Drug.
LOS ANGELES -- Following a management meeting in San Francisco on June 7, representatives of CytoDyn, Inc. (Pink Sheets: CYDY) will be meeting wit...
See the full content of this document
Sponsored links
